Kirkland & Ellis acted as legal counsel to Eli Lilly, while for Versanis, Goodwin Procter acted as legal counsel and Cooley advised as to patent matters....
Eli Lilly’s $1.925 Billion Acquisition of Versanis Bio
K36 Therapeutics’ $70 Million Series B Financing Round
Goodwin advised K36 Therapeutics on the financing. K36 Therapeutics announced a $70M Series B financing. The round was led by Nextech Invest, Ltd, a precision medicine focused...
Bicara Therapeutics’ $108 Million Series B Financing
Goodwin Procter advised Bicara Therapeutics on the deal. Bicara Therapeutics announced the completion of its oversubscribed $108 million Series B financing to advance the company’s lead program...